Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00268476
Title Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Medical Research Council
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisolone

Metformin

Abiraterone + Enzalutamide + Prednisolone

Celecoxib

Estradiol

Zoledronic acid

Docetaxel + Prednisolone

Docetaxel + Prednisolone + Zoledronic acid

Celecoxib + Zoledronic acid

Age Groups: adult | senior
Covered Countries


No variant requirements are available.